Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

MCTS1 antibody (AA 1-181)

MCTS1 Reactivity: Human ELISA, IHC, IF Host: Rabbit Polyclonal unconjugated
Catalog No. ABIN7158949
  • Target See all MCTS1 Antibodies
    MCTS1 (Malignant T Cell Amplified Sequence 1 (MCTS1))
    Binding Specificity
    • 16
    • 7
    • 7
    • 7
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1-181
    Reactivity
    • 49
    • 13
    • 11
    • 7
    • 7
    • 6
    • 6
    • 2
    • 1
    • 1
    • 1
    Human
    Host
    • 48
    • 2
    • 1
    Rabbit
    Clonality
    • 49
    • 2
    Polyclonal
    Conjugate
    • 28
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    This MCTS1 antibody is un-conjugated
    Application
    • 44
    • 18
    • 15
    • 14
    • 13
    • 7
    • 6
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)
    Cross-Reactivity
    Human
    Purification
    >95%, Protein G purified
    Immunogen
    Recombinant Human Malignant T-cell-amplified sequence 1 protein (1-181AA)
    Isotype
    IgG
    Top Product
    Discover our top product MCTS1 Primary Antibody
  • Application Notes
    Recommended dilution: IHC:1:20-1:200, IF:1:200-1:500,
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4
    Preservative
    ProClin
    Precaution of Use
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    -20 °C,-80 °C
    Storage Comment
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target
    MCTS1 (Malignant T Cell Amplified Sequence 1 (MCTS1))
    Alternative Name
    MCTS1 (MCTS1 Products)
    Synonyms
    MCT-1 antibody, MCT1 antibody, MCT1a antibody, cb517 antibody, zgc:55682 antibody, 1500019M23Rik antibody, zgc:56242 antibody, mcts1 antibody, MGC89874 antibody, MCTS1 antibody, MCT-1A antibody, mct-1 antibody, mct1 antibody, MCT-1B antibody, mcts1-a antibody, mcts1-b antibody, MCTS1, re-initiation and release factor antibody, solute carrier family 16 (monocarboxylate transporter), member 1b antibody, malignant T cell amplified sequence 1 antibody, malignant T-cell amplified sequence 1 antibody, solute carrier family 16 member 1 antibody, malignant T-cell amplified sequence 1 S homeolog antibody, monocarboxylate transporter 1 antibody, malignant T-cell amplified sequence 1 L homeolog antibody, MCTS1 antibody, slc16a1b antibody, Mcts1 antibody, mcts1 antibody, SLC16A1 antibody, mcts1.S antibody, MCT1 antibody, mcts1.L antibody
    Background

    Background: Anti-oncogene that play a role in cell cycle regulation, decreases cell doubling time and anchorage-dependent growth, shortens the duration of G1 transit time and G1/S transition. When constituvely expressed, increases CDK4 and CDK6 kinases activity and CCND1/cyclin D1 protein level, as well as G1 cyclin/CDK complex formation. Involved in translation initiation, promotes recruitment of aminoacetyled initiator tRNA to P site of 40S ribosomes. Can promote release of deacylated tRNA and mRNA from recycled 40S subunits following ABCE1-mediated dissociation of post-termination ribosomal complexes into subunits. Plays a role as translation enhancer, recruits the density-regulated protein/DENR and binds to the cap complex of the 5\'-terminus of mRNAs, subsequently altering the mRNA translation profile, up-regulates protein levels of BCL2L2, TFDP1, MRE11A, CCND1 and E2F1, while mRNA levels remains constant. Hyperactivates DNA damage signaling pathway, increased gamma-irradiation-induced phosphorylation of histone H2AX, and induces damage foci formation. Increases the overall number of chromosomal abnormalities such as larger chromosomes formation and multiples chromosomal fusions when overexpressed in gamma-irradiated cells. May play a role in promoting lymphoid tumor development: lymphoid cell lines overexpressing MCTS1 exhibit increased growth rates and display increased protection against apoptosis. May contribute to the pathogenesis and progression of breast cancer via promotion of angiogenesis through the decline of inhibitory THBS1/thrombospondin-1, and inhibition of apoptosis. Involved in the process of proteasome degradation to down-regulate Tumor suppressor p53/TP53 in breast cancer cell, Positively regulates phosphorylation of MAPK1 and MAPK3. Involved in translation initiation, promotes aminoacetyled initiator tRNA to P site of 40S ribosomes. Can promote release of deacylated tRNA and mRNA from recycled 40S subunits following ABCE1-mediated dissociation of post-termination ribosomal complexes into subunits.

    Aliases: FLJ39637 antibody, Malignant T cell amplified sequence 1 antibody, Malignant T cell-amplified sequence 1 antibody, MCT 1 antibody, MCT-1 antibody, MCT1 antibody, MCTS 1 antibody, MCTS1 antibody, MCTS1_HUMAN antibody, Multiple copies T cell malignancies 1 antibody, Multiple copies T cell malignancies antibody, Multiple copies T-cell malignancies antibody, Oncogene MCT 1 antibody, Oncogene MCT1 antibody

    UniProt
    Q9ULC4
You are here: